Extracellular Vesicle-Carried GTF2I from Mesenchymal Stem Cells Promotes the Expression of Tumor-Suppressive FAT1 and Inhibits Stemness Maintenance in Thyroid Carcinoma
The effects of bone marrow mesenchymal stem cell-derived extracellular vesicles enriched with GTF2I were evaluated on the epithelial–to–mesenchymal transition and stemness maintenance in thyroid carcinoma.